Surgical treatment of giant GIST of the cardiac stomach
https://doi.org/10.24884/0042-4625-2019-178-4-61-63
Abstract
The article describes the observation of successful radical surgical treatment of a giant gastrointestinal stromal tumor of the cardiac stomach in the patient with concomitant pathology: type 2 diabetes mellitus, insulin-dependent, hypertensive disease of stage 3, severe anemia.
About the Authors
A. L. Charyshkin
Ulyanovsk state University
Russian Federation
Russian Federation
12 L’va Tolstogo street, Ulyanovsk, Russia, 432017
E. A. Toneev
Ulyanovsk state University,
Regional clinical Oncology center, chief Valery G. Bazyuk
Russian Federation
12 L’va Tolstogo street, Ulyanovsk, Russia, 432017
Russian Federation
12 L’va Tolstogo street, Ulyanovsk, Russia, 432017
A. A. Martynov
Regional clinical Oncology center, chief Valery G. Bazyuk
Russian Federation
Russian Federation
D. A. Semenov
Regional clinical Oncology center, chief Valery G. Bazyuk
Russian Federation
Russian Federation
References
1. Никулин М.П., Стилиди И.С. Гастроинтестинальные стромальные опухоли(ГИСО). Эпидемиология, диагностика, современные подходы к лечению // Современная онкология. Экстра-выпуск. 2007. С. 3–50. [Nikulin M.P., Stilidi I.S. Gastrointestinal'nye stromal'nye opukholi(GISO). Ehpidemiologiya, diagnostika, sovremennye podkhody k lecheniyu // Modern oncology. Extra, extra 2007. p. 3–50.(In Russ.)].
2. Kindblom L. G., Remotti H. E., Aldenborg F., Meis-Kindblom J. M. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal// The American Journal of Pathology. 1998;152(5):1259–1269.
3. Архири П.П., Цымжитова Н.Ц., Стилиди И.С. Клиническое и прогностическое значение мутационного статуса у больных гастроинтестинальными стромальными опухолями // Саркомы костей, мягких тканей и опухоли кожи. 2013. № 1. С. 42–46. [Аrkhiri P.P., TSymzhitova N.TS., Stilidi I.S. Klinicheskoe i prognosticheskoe znachenie mutatsionnogo statusa u bol'nykh gastrointestinal'nymi stromal'nymi opukholyami // Bone sarcomas, soft tissue and skin tumors.2013. № 1. p. 42–46. (In Russ.)].
4. Miettinen M., Lasota J. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics//Pol. J. Pathol. 2003. № 54. Р. 3–24.
5. Joensuu H., Eriksson M., Hatrmann J. et al. Twelve versus 36 months of adjuvant imatinib (IM) as treatment of operable GIST with a high risk of recurrence: Final results of a randomized trial (SSGXVIII/AIO)// J. Clin. Oncol. ASCO Annual Meeting Proceedings (PostMeeting Edition). 2011. Vol. 29. № 18. Suppl. Abstract LBA1
6. Steigen S. E., Eide T. J. Gastrointestinal stromal tumors (GISTs): a review// APMIS. 2009;117(2):73–86. doi: 10.1111/j.1600-0463.2008.00020.x
7. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors//Science 1998;279:577-80. 10.1126/science.279.5350.577
8. van der Zwan SM, DeMatteo RP. Gastrointestinal stromal tumor: 5 years later//Cancer. 2005;104:1781–1788
9. Valsangkar N, Sehdev A, Misra S, et al. Current management of gastrointestinal stromal tumors: surgery, current biomarkers, mutations, and therapy. Surgery 2015;158:1149-64. 10.1016/j.surg.2015.06.027
10. Blay J.Y. A decade of tyrosine kinase inhibitor therapy: Historical and current perspectives on targeted therapy for GIST //Cancer Treat. Rev. 2011. Vol. 37. № 5. P. 373–384
Review
For citations:
Charyshkin A.L., Toneev E.A., Martynov A.A., Semenov D.A. Surgical treatment of giant GIST of the cardiac stomach. Grekov's Bulletin of Surgery. 2019;178(4):61-63. (In Russ.) https://doi.org/10.24884/0042-4625-2019-178-4-61-63
Views:
541
Email this article 